BibTex format
@article{Delgado-SanMartin:2026:10.1038/s44325-026-00114-9,
author = {Delgado-SanMartin, JA and Keles, M and Errington, N and Schuetz, N and Johnson, A and Gupta, V and Hershman, S and Toshner, M and Wilkins, MR and Kiely, DG and Thompson, R and Ashley, E and Wang, D and Lawrie, A},
doi = {10.1038/s44325-026-00114-9},
journal = {NPJ Cardiovasc Health},
title = {Assessing the feasibility of using smartphone data to identify risk of idiopathic pulmonary arterial hypertension.},
url = {http://dx.doi.org/10.1038/s44325-026-00114-9},
volume = {3},
year = {2026}
}
RIS format (EndNote, RefMan)
TY - JOUR
AB - Idiopathic pulmonary arterial hypertension (IPAH) is a progressive, life-limiting condition often diagnosed late due to non-specific symptoms and requirement of invasive right heart catheterisation. This pilot study explores the feasibility of using real-world physical activity data from wearable devices and a smartphone app (My Heart Counts) to aid earlier detection. We analysed up to eight years of retrospective data from 109 UK participants, including patients with IPAH, disease controls, and healthy individuals. A classifier trained on pre-diagnostic activity and heart rate, distinguished individuals with IPAH from healthy and disease controls with an ROC AUC of 0.87, improving to 0.94 with in-app questionnaire input. Validation in a matched US cohort yielded an ROC AUC of 0.74. Wearable-derived metrics correlated with clinical 6MWD supporting their potential to complement traditional risk assessment. These pilot findings suggest that digital health tools may support earlier detection and remote monitoring of IPAH warranting larger scale studies.
AU - Delgado-SanMartin,JA
AU - Keles,M
AU - Errington,N
AU - Schuetz,N
AU - Johnson,A
AU - Gupta,V
AU - Hershman,S
AU - Toshner,M
AU - Wilkins,MR
AU - Kiely,DG
AU - Thompson,R
AU - Ashley,E
AU - Wang,D
AU - Lawrie,A
DO - 10.1038/s44325-026-00114-9
PY - 2026///
TI - Assessing the feasibility of using smartphone data to identify risk of idiopathic pulmonary arterial hypertension.
T2 - NPJ Cardiovasc Health
UR - http://dx.doi.org/10.1038/s44325-026-00114-9
UR - https://www.ncbi.nlm.nih.gov/pubmed/41882158
VL - 3
ER -